Properties
Description
BTT-3033 is an effective cytoskeleton inhibitor, that has the ability to prevent the pathway of cytoskeletal signaling by inhibiting integrin.
Molecular Formula
C23H20FN5O3S
Titer
Free from inappropriate visible particulates, foreign matter, discoloration, or other defects
Applications
BTT-3033 is a cytoskeletal signaling inhibitor that plays a key role in targeting integrin αvβ3, which is involved in tumor angiogenesis and metastasis.